Xanthelasmata Predict Death, Ischemic Vascular Disease

Xanthelasmata either alone or combined with arcus corneae predict risk in general population

FRIDAY, Sept. 16 (HealthDay News) -- Xanthelasmata either individually or in combination with arcus corneae, but not arcus corneae alone, predict the risk of ischemic vascular disease and death in the general population, according to a study published online Sept. 15 in BMJ.

Mette Christoffersen, from the Rigshospitalet in Denmark, and colleagues investigated whether xanthelasmata (563 cases) and arcus corneae (3,159 cases), either individually or in combination, predict the risk of ischemic vascular disease and death in the general population. A total of 12,745 individuals (aged 20 to 93 years), who were free from vascular disease at baseline, were followed up from 1976-1978 to May 2009. Odds ratios (ORs) were estimated for severe atherosclerosis, and hazard ratios (HR) for 1,872 cases of myocardial infarction (MI), 3,699 ischemic heart disease (IHD), 1,498 ischemic strokes, 1,815 ischemic cerebrovascular disease (CVD), and 8,507 deaths.

The investigators found that the multifactorially adjusted HRs/ORs for individuals with xanthelasmata versus those without, and for individuals with combined xanthelasmata and arcus corneae versus those without were 1.48 and 1.47 (MI), 1.39 and 1.56 (IHD), 0.94 and 0.87 (ischemic stroke), 0.91 and 0.86 (ischemic CVD), 1.69 and 2.75 (severe atherosclerosis), and 1.14 and 1.09 (death), respectively. The ratios for arcus corneae were not significant. The presence of xanthelasmata increased the absolute 10-year risk of MI, IHD, and death in all age-groups and genders. The highest absolute 10-year risks of IHD in individuals aged 70 to 79 years with and without xanthelasmata were 53 and 41 percent, respectively, for men, and 35 and 27 percent, respectively, for women.

"Xanthelasmata predict risk of MI, IHD, severe atherosclerosis, and death in the general population," the authors write.

Abstract
Full Text
Editorial (subscription or payment may be required)

Copyright © 2011 HealthDay. All rights reserved.

Powered by

jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

Nursing Jobs Plus
Featured Jobs
Recommended CE Articles

Debunking Three Rape Myths
Journal of Forensic Nursing, October/December 2014
Expires: 12/31/2016 CE:2.5 $24.95


Drug updates and approvals: 2014 in review
The Nurse Practitioner, 13December 2014
Expires: 12/31/2016 CE:3 $27.95


Can Food Processing Enhance Cancer Protection?
Nutrition Today, September/October 2014
Expires: 10/31/2016 CE:2 $21.95


More CE Articles

Subscribe to Recommended CE

Recommended Nursing Articles Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events